Purchase Order 36C26326P0367

The Department of Veterans Affairs, Veterans Integrated Service Network 23 (Minneapolis) awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC for transcatheter aortic valve replacement (TAVR) systems on April 3, 2026, with an ultimate completion date of April 6, 2026. This contract was awarded without a set-aside designation and represents a direct procurement of specialized cardiovascular medical devices essential to the VA's cardiac surgical programs. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, specializes in the design and manufacture of advanced cardiovascular devices, including transcatheter heart valves and related cardiac technologies.

This purchase order is part of Edwards Lifesciences LLC's extensive business relationship with the Department of Veterans Affairs, under which the company has received over 200 prime federal contract awards since 2025, predominantly from multiple Veterans Integrated Service Networks. The company also operates under two indefinite delivery contracts with the VA totaling $7.45 million: a $6.5 million five-year consignment contract with VISN 21 (Palo Alto) effective through December 31, 2030, and a $950,000 five-year contract with VISN 15 effective through October 19, 2030. These framework agreements establish Edwards Lifesciences LLC as the primary supplier of advanced cardiovascular devices across key VA service networks, ensuring consistent availability of specialized surgical implants and transcatheter heart valves to support veteran cardiac care.